Vimarsana
Biggest News Aggregation in the World

Ruby Coil System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ruby Coil System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ruby Coil System Today - Breaking & Trending Today

Penumbra, Inc. : The underdog in healthcare -April 11, 2024 at 09:39 pm EDT - Vimarsana News

Penumbra, Inc. : The underdog in healthcare -April 11, 2024 at 09:39 pm EDT

Founded in 2004, Penumbra has grown into a global healthcare company specializing in innovative therapies. With over 4000 employees, the company offers products in more than 100 markets worldwide....

Penumbra (NYSE:PEN) Upgraded by Zacks Investment Research to "Hold" - Vimarsana News

Penumbra (NYSE:PEN) Upgraded by Zacks Investment Research to "Hold"

Penumbra (NYSE:PEN – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company’s portfolio of products primarily addresses neuro […]

Penumbra (NYSE:PEN) Downgraded by Zacks Investment Research - Vimarsana News

Penumbra (NYSE:PEN) Downgraded by Zacks Investment Research

Penumbra (NYSE:PEN – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company’s portfolio of products primarily addresses […]

Penumbra (NYSE:PEN) Stock Rating Lowered by Zacks Investment Research - Vimarsana News

Penumbra (NYSE:PEN) Stock Rating Lowered by Zacks Investment Research

Penumbra (NYSE:PEN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports. According to Zacks, “Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company’s portfolio of products […]